Skip to main content
Log in

Membrane and cytoplasmic changes in 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell lines

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Human glioma-derived cell lines previously determined by a microtiter chemotherapy assay to be either ‘sensitive’ or ‘resistant’ to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) were treated with BCNU (1–80 µg/ml) and observed using microcinematography, scanning electron microscopy, and transmission electron microscopy. Striking bleb formation and cell retraction were observed to occur in a dose-dependent relationship within minutes in the cells known to be BCNU-sensitive. At 15µg/ ml, 69% of cells showed blebs by 30 min, 87% by 90 min, and 100% by 4 hr. This activity was not seen in BCNU-resistant cells. These morphological changes occur at a time too early to be accounted for by the known BCNU mechanism of DNA alkylation and cross-link formation and suggest that cytoplasmic and/or membrane events may be significant initial events in the cytotoxic actions of BCNU.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kornblith PL, Szypko PE: Variations in response of human brain tumors to BCNU in vitro. J Neurosurg 48: 580–586, 1978.

    Google Scholar 

  2. Kornblith PL, Smith BH, Leonard LA: Response of cultured human brain tumors to nitrosoureas: correlation with clinical data. Cancer 47: 255–265, 1981.

    Google Scholar 

  3. Wheeler GP: Mechanism of action of alkylating agents: nitrosourea. In: Sartorelli AC, Johns DG (eds) Antineoplastic and immunosuppressive agents. Handbook of experimental pharmacology. Springer-Verlag, Berlin, New York, vol 38, pt 2, 1975, pp 65–84.

    Google Scholar 

  4. Wheeler GP: A review on studies on the mechanisms of action of nitrosoureas. In: Sartorelli AC (ed) Cancer chemotherapy. Am Chem Soc Symp, Washington D.C. vol 30, 1976, pp 87–119.

    Google Scholar 

  5. Kann HE Jr: Comparison of biochemical and biological effects of four nitrosoureas with differing carbamoylating activities. Cancer Res 38: 2363–2366, 1978.

    Google Scholar 

  6. Montgomery JA: Chemistry and structure-activity studies of the nitrosoureas. Cancer Treat Rep 60: 651–654, 1976.

    Google Scholar 

  7. Kohn KW: Interstrand cross-linking of DNA by 1,3-bis (2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-l-nitrosoureas. Cancer Res 37: 1450–1454, 1977.

    Google Scholar 

  8. Fornace AJ Jr, Kohn K Jr, Kann HE Jr: Inhibition of the ligase step of excision repair by 2-chloroethyl isocyanate, a decomposition product of 1,3-bis (2-chloroethyl)-1-nitrosourea. Cancer Res: 38: 1064–1069, 1978.

    Google Scholar 

  9. Kann HE Jr, Kohn KW, Lyles JM: Inhibition of DNA repair by the 1,3-bis (2-chloroethyl)-l-nitrosourea breakdown product, 2-chloroethyl isocyanate. Cancer Res 34: 398–402, 1974.

    Google Scholar 

  10. Erickson LC, Bradley MO, Kohn KW: Differential inhibition of the rejoining of x-ray induced DNA strand breaks in normal and transformed human fibroblasts treated with 1,3-bis(2-chloroethyl)-l-nitrosourea in vitro. Cancer Res 38: 672–677, 1978.

    Google Scholar 

  11. Erickson LC, Laurent G, Sharkey NA, Kohn KW: DNA cross-linking and monoadduct repair in nitrosourea-treated human tumor cells. Nature 288: 727–729, 1980.

    Google Scholar 

  12. Baril BB, Baril EF, Laszlo J, Wheeler GP: Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates. Cancer Res 35: 1–5, 1975.

    Google Scholar 

  13. Chuang RY, Laszlo J, Keller P: Effects of nitrosoureas on human DNA polymerase activities from acute and chronic granulocytic leukemia cells. Biochim Biophys Acta 425: 463–468, 1976.

    Google Scholar 

  14. Abelson HT, Karlan D, Pennman S: A comparison of the effects of alkylating agents 1,3-bis (2-chloroethyl)-1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, and nitrogen mustard on nuclear RNA synthesis and processing. Biochim Biophys Acta 349: 389–401, 1974.

    Google Scholar 

  15. Kann HE Jr, Kohn KW, Widerlite L, Gullion D: Effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compound on nuclear RNA metabolism. Cancer Res 34: 1982–1988, 1974.

    Google Scholar 

  16. Broome MG, Kornblith PL: Uptake and release of BCNU by human glial cells and effect of drug on macromolecular synthesis (abstract). In Vitro 14: 377, 1978.

    Google Scholar 

  17. Ludlum DB: Alkylating agents and the nitrosoureas. In: Becker FF (ed) Cancer: A comprehensive treatise. Plenum Press, New York, 1977, vol 5, pp 285–307.

    Google Scholar 

  18. Day RS III, Ziolkowski CHJ: Human brain tumor cell strains with deficient host-cell reactivation of N-methyl-N′-nitro-N nitrosoguanidine-damaged adenovirus 5. Nature 279: 797–799, 1979.

    Google Scholar 

  19. Day RS III, Ziolkowski CHJ, Scudiero DA, Meyer SA, Mattern MR: Human tumor cell strains defective in the repair of alkylation damage. Carcinogenesis 1: 21–32, 1980.

    Google Scholar 

  20. Black PMcL, Kornblith PL, Davison PF, Liszczak TM, Merk LP, Smith BH, McKeever PE, Quindlen EA: Immunological, biochemical, ultrastructural and electrophysiological characteristics of a human glioblastoma-derived cell culture line. J Neurosurg 56: 62–72, 1982.

    Google Scholar 

  21. Kornblith PL, Prieto A Jr, Pollen DA: Alterations in glial and mesenchymal tumor cell membrane resistance with heteroimmune and autologous sera. Ann NY Acad Sci 159: 585–590, 1969.

    Google Scholar 

  22. Lightbody J, Pfeiffer SE, Kornblith PL, Herschman H: Biochemically differentiated clonal human glial cells in tissue culture. J Neurobiol 1: 411–417, 1970.

    Google Scholar 

  23. McKeever PE, Quindlen EA, Banks MA, Williams U, Kornblith PL, Laverson S, Greenwood MA, Smith BH: Biosynthesized products of cultured neuroglial cells: I. Selective release of proteins by cells from human astrocytomas. Neurology 31: 1445–1452, 1981.

    Google Scholar 

  24. Trachtenberg MC, Kornblith PL, Hauptli J: Biophysical properties of cultured human glial cells. Brain Res 38: 279–298, 1972.

    Google Scholar 

  25. Weinstein RS, Kornblith PL: Ultrastructure of a cloned astrocytoma in tissue culture. Cancer 27: 1174–1181, 1971.

    Google Scholar 

  26. Wilson CB, Kornblith PL: Experimental brain tumors and experimental chemotherapy. In: Tower DB (ed) The nervous system. The clinical neuroscience. Raven Press, New York, 1975, vol 2, pp 175–181.

    Google Scholar 

  27. Shitara N, McKeever PE, Wang-PengJ, Smith BH, Schmidt S, Kornblith PL: Flowcytometric and cytogenetic analysis of human brain tumors. In preparation.

  28. Coakham HB, Kornblith PL, Quindlen EA, Pollock LA, Wood WC, Hartnett LC: Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. J Natl Cancer Inst 64: 223–233, 1980.

    Google Scholar 

  29. Kornblith PL, Coakham HB, Pollock LA, Wood WC, Green SB, Smith BH: Autologous serological responses in glioma patients: correlation with tumor grade and survival. Submitted to Cancer, 1982.

  30. Levin VA, Hoffman W, Weinkam J: Pharmacokinetics of BCNU in man: a preliminary study of 20 patients. Cancer Treat Rep 62: 1305–1312, 1978.

    Google Scholar 

  31. DeVita VT, Denham C, Davidson JD, Oliverio VT: The physiological disposition of the carcinostatic 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) in man and animals. Clin Pharmacol Ther 8:566–577, 1967.

    Google Scholar 

  32. Chatterji D, Greene R, Galleli J: Mechanisms of hydrolysis of halogenated nitrosoureas. J Pharm Sci 67: 1527–1532, 1978.

    Google Scholar 

  33. Russo R, Bartosek I, Piazza E, Santi A, Libretti A, Garatini S Differential pulse polarographic determination of BCNU pharmacokinetics in patients with lung cancer. Cancer Treat Rep 65:555–562, 1981.

    Google Scholar 

  34. Hanawalt PC, Setlow RB: Molecular mechanisms for repair of DNA. Plenum Press, New York 1975, p 843.

    Google Scholar 

  35. Altmann H, Schattauer F: DNA repair mechanisms. Schattauer-Verlag, Stuttgart, New York, 1972, pp 248.

    Google Scholar 

  36. Strauss B, Coyle M, Robbins M: Consequences of alkylation for the behavior of DNA. Ann NY Acad Sci 163: 765–787, 1969.

    Google Scholar 

  37. Allred LE, Porter KR: Morphology of normal and transformed cells. In: Hynes RO (ed) Surfaces of normal and malignant cells. Wiley, New York, 1979, pp 21–61.

    Google Scholar 

  38. Porter KR, Fonte VG, Weiss GE: A scanning microscope study of the topography of HeLa cells. Cancer Res 34: 1385–1394, 1974.

    Google Scholar 

  39. Taylor AC, Robbins E: Observations on microextensions from the surface of isolated vertebrate cells. Dev Biol 7: 660–673, 1963.

    Google Scholar 

  40. Bragina EE, Vasliliev JM, Gelfand IM: Formation of bundles of microfilaments during spreading of fibroblasts on the substrate. Exp Cell Res 97: 241–248, 1976.

    Google Scholar 

  41. Byers B, Abramson DH: Cytokinesis in HeLa: post-telephase delay and microtubule-associated motility. Protoplasma 66: 413–435, 1968.

    Google Scholar 

  42. Follett EAC, Goldman RD: The occurrence of microvilli during spreading and growth of BILK 21/03 fibroblasts. Exp Cell Res 59: 124–136, 1970.

    Google Scholar 

  43. Porter KR, Prescott DM, Frye J: Changes in surface morphology of Chinese hamster ovary cells curing the cell cycle. J Cell Biol 57: 815–836, 1973.

    Google Scholar 

  44. Bowman PD, Daniel CW: Aging of human fibroblasts in vitro surface features and behavior of aging WI-38 cells. Mech Ageing Dev 4: 147–158, 1975.

    Google Scholar 

  45. Erickson CA, Trinkaus JP: Microvilli and blebs as sources of reserve surface membrane during cell spreading. Exp Cell Res 99: 375–384, 1976.

    Google Scholar 

  46. Godman GC, Miranda AF, Deitch AD, Tanenbaum SW: Action of cytochalasin B on cells of established lines. III. Zeiosis and movements at the cell surface. J Cell Biol 64: 644–667, 1975.

    Google Scholar 

  47. Porter KR, Puck TT, Hsie AW, Kelley D: An electron microscope study of the effects of dibutyryl cyclic AMP on Chinese hamster ovary cells. Cell 2: 145–162, 1974.

    Google Scholar 

  48. Puck TT, Waldren CA, Hsie AW: Membrane dynamics in the action of dibutyryl adenosine 3′:5′-cyclic monophosphate and testosterone on mammalian cells. Proc Nat Acad Sci USA 69: 1943–1947, 1972.

    Google Scholar 

  49. Jewell S, Bellamo G, Thor H, Orrenius S, Smith M: Bleb formation in hepatocytes during drug metabolism is caused by disturbances in thiol and calcium ion homeostasis. Science 217: 1257–1259, 1982.

    Google Scholar 

  50. Nathan CF, Arrick BA, Murray HW, DeSantis MM, Cohn ZA: Tumor cell anti-oxidant defenses: Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. J Exp Med 153: 766–782, 1981.

    Google Scholar 

  51. Wheeler GP: Studies related to mechanisms of resistance to biological alkylating agents. Cancer Res 23: 1334–1349, 1963.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Address for reprints: Barry H. Smith, M.D., Ph.D., Surgical Neurology Branch, NINCDS, NIH, Bldg. I OA, Rm. 3E68, Bethesda, MD 20205, USA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, B.H., Vaughan, M., Greenwood, M.A. et al. Membrane and cytoplasmic changes in 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell lines. J Neuro-Oncol 1, 237–248 (1983). https://doi.org/10.1007/BF00165608

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165608

Keywords

Navigation